Showing results (211-220 of 435) with videos related to
Sort By:
Pageof 44
Frontiers in Oncology|October 10, 2022
Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenograftsPreeti Kanikarla Marie, Alexey V Sorokin, Lea A Bitner, et al.British Journal of Cancer|June 9, 2016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancerMichael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, et al.Bioinformatics (Oxford, England)|June 12, 2021
Methylation-eQTL analysis in cancer researchYusha Liu, Keith A Baggerly, Elias Orouji, et al.Research Square|April 1, 2024
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapiesAkram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2014
Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patientsKeun-Wook Lee, Sung Sook Lee, Sang-Bae Kim, et al.Biorxiv : the Preprint Server for Biology|December 25, 2025
Functional modules predict cancer-relevant genetic interactions in mammalian cellsChenchu Lin, Veronica Gheorghe, Juihsuan Chou, et al.Clinical Colorectal Cancer|September 13, 2018
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic CharacteristicsMaliha Khan, Jonathan M Loree, Shailesh M Advani, et al.Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.Cancers|February 24, 2024
Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA ProfilingBenny Johnson, Van Morris, Xuemei Wang, et al.Cancer Research|August 1, 2022
Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6Alexey V Sorokin, Preeti Kanikarla Marie, Lea Bitner, et al.Pageof 44